The programme’s mission is around making medicines better, through optimisation of current treatments, understanding variability in patient responses from both an efficacy and safety perspective, and formulation of advanced therapeutics such as nanomedicines and cellular therapies, and making better medicines by developing the next generation of therapeutics. All of this is underpinned by a robust understanding of the processes that govern the biodistribution, pharmacokinetics, pharmacodynamics, and safety of these new, and improved, therapeutics.
The program is led by internationally recognised experts in the field of Pharmacology, Toxicology, and Biocompatibility from both non-clinical and clinical departments. In practice, we will provide an in-depth curriculum of the processes underlying these areas, as well as the clinical and regulatory processes aligned to them. We will utilise real-world case studies of therapeutics under development by experts involved in these research areas prior to you joining one of these teams for the implementation of the final research project.
You will be taught by internationally-renowned infection and health scientists and clinicians in practice, to provide in-depth scientific knowledge and you will receive training for research that can be applied to academic, commercial and healthcare settings. In addition, you will learn digital, programming and informatic skills that are of increasing importance for research and many employers.
Normally, at least a 2.1 Honours degree in a Biological Sciences subject or equivalent. Candidates must have a scientific background acceptable to the Programme Director. Candidates from non-English speaking countries must demonstrate an ability of English Language equivalent to IELTS 6.5.
This programme aims to provide you with the necessary knowledge and skills to become professional scientists in the multidisciplinary areas of Pharmacology and Toxicology. Graduates have developed careers in conservation or qualified to immediately go into the Pharmaceutical and Biotechnology industries. Commercial sectors such as the pharmaceutical, biotechnology and agriculture industries will be possible employers of graduates, especially with the anticipated increases in the development of new therapeutics, to meet emerging infectious diseases. In the public sector, researchers are in demand in research institutes, government departments, the Health Service, forensic science and the Environment Agency.
For those committed to a career as a research scientist, this programme will qualify you to be able to take up PhD studies, research posts in academia or in industry or management posts in clinical trial units.
Dr Neill Liptrott, Reader in Pharmacology and Immnocompatibility
Back to: Study